Abstract
Peptidylarginine deiminases (PADs) are a group of posttranslational modification enzymes that citrullinate (deiminate) protein arginine residues in a calcium ion-dependent manner. Enzymatic citrullination abolishes the positive charges of native protein molecules, inevitably causing significant alterations in their structure and functions. Protein citrullination is important for the formation of the cornified layer of the skin that covers the human body. Despite this beneficial function, protein citrullination can also be detrimental as its accumulation in the brain is a possible cause of Alzheimer’s disease (AD). In this chapter, we introduce PADs and their protein citrullination function now considered critical for advancing research on aging and neurodegenerative disorders, especially AD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- Anti-CCP:
-
Anti-cyclic citrullinated peptide
- Anti-MVC:
-
Anti-mutated citrullinated vimentin
- BAEE:
-
Benzoyl-l-arginine ethyl ester
- Bz-l-Arg:
-
Benzoyl-l-arginine
- Calbindin:
-
Calbindin-D-28K
- cAMP:
-
Cyclic adenosine monophosphate
- Cit-GFAP:
-
Citrullinated glial fibrillary acidic protein
- Cit-hGFAP:
-
Citrullinated human glial fibrillary acidic protein
- Cit-rhGFAP:
-
Citrullinated recombinant human glial fibrillary acidic protein
- CNS:
-
Central nervous system
- dbcAMP:
-
Dibutyryl cyclic adenosine monophosphate
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- GFAP:
-
Glial fibrillary acidic protein
- MALDI-TOF:
-
Matrix-associated laser desorption ionization-time of flight
- MAP 2:
-
Microtubule-associated protein 2
- MBP:
-
Myelin basic protein
- Nef3:
-
Neurofilament 3
- NFT:
-
Neurofibrillary tangles
- PAD:
-
Peptidylarginine deiminase
- PKA:
-
Protein kinase A
- qPCR:
-
Quantitative real-time polymerase chain reaction
- RA:
-
Rheumatoid arthritis
- rhGFAP:
-
Recombinant human glial fibrillary acidic protein
- rhPAD:
-
Recombinant human peptidylarginine deiminase
- RT-PCR:
-
Reverse transcription polymerase chain reaction
- SP:
-
Senile plaque
- β2-MG:
-
β2-microglobulin
References
Akiyama, K., Sakurai, Y., Asou, H., & Senshu, T. (1999). Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere. Neuroscience Letters, 274(1), 53–55.
Asaga, H., & Ishigami, A. (2000). Protein deimination in the rat brain: Generation of citrulline-containing proteins in cerebrum perfused with oxygen-deprived media. Biomedical Research, 21(4), 197–205.
Asaga, H., & Ishigami, A. (2001). Protein deimination in the rat brain after kainate administration: Citrulline-containing proteins as a novel marker of neurodegeneration. Neuroscience Letters, 299(1–2), 5–8.
Asaga, H., & Senshu, T. (1993). Combined biochemical and immunocytochemical analyses of postmortem protein deimination in the rat spinal cord. Cell Biology International, 17(5), 525–532.
Asaga, H., Yamada, M., & Senshu, T. (1998). Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochemical and Biophysical Research Communications, 243(3), 641–646.
Asaga, H., Nakashima, K., Senshu, T., Ishigami, A., & Yamada, M. (2001). Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. Journal of Leukocyte Biology, 70(1), 46–51.
Asaga, H., Akiyama, K., Ohsawa, T., & Ishigami, A. (2002). Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain. Neuroscience Letters, 326(2), 129–132.
Bartzokis, G. (2004). Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer’s disease. Neurobiology of Aging, 25(1), 5–18. author reply 49–62.
Boyde, T. R., & Rahmatullah, M. (1980). Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Analytical Biochemistry, 107(2), 424–431.
Chavanas, S., Mechin, M. C., Takahara, H., Kawada, A., Nachat, R., Serre, G., & Simon, M. (2004). Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene, 330, 19–27.
Cheron, G., Servais, L., & Dan, B. (2008). Cerebellar network plasticity: From genes to fast oscillation. Neuroscience, 153(1), 1–19.
Choi, D. W. (1988). Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends in Neurosciences, 11(10), 465–469.
Erickson, M. A., Haburcak, M., Smukler, L., & Dunlap, K. (2007). Altered functional expression of Purkinje cell calcium channels precedes motor dysfunction in tottering mice. Neuroscience, 150(3), 547–555.
Gould, R. M., Freund, C. M., Palmer, F., & Feinstein, D. L. (2000). Messenger RNAs located in myelin sheath assembly sites. Journal of Neurochemistry, 75(5), 1834–1844.
Guerrin, M., Ishigami, A., Mechin, M. C., Nachat, R., Valmary, S., Sebbag, M., Simon, M., Senshu, T., & Serre, G. (2003). cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. The Biochemical Journal, 370(Pt 1), 167–174.
Halvorsen, E. H., Pollmann, S., Gilboe, I. M., van der Heijde, D., Landewe, R., Odegard, S., Kvien, T. K., & Molberg, O. (2008). Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Annals of the Rheumatic Diseases, 67(3), 414–417.
Haun, S. E., Murphy, E. J., Bates, C. M., & Horrocks, L. A. (1992). Extracellular calcium is a mediator of astroglial injury during combined glucose-oxygen deprivation. Brain Research, 593(1), 45–50.
Hossmann, K. A. (1999). The hypoxic brain. Insights from ischemia research. Adv. Exp. Med. Biol., 474, 155–169.
Imparl, J. M., Senshu, T., & Graves, D. J. (1995). Studies of calcineurin-calmodulin interaction: Probing the role of arginine residues using peptidylarginine deiminase. Archives of Biochemistry and Biophysics, 318(2), 370–377.
Inagaki, M., Takahara, H., Nishi, Y., Sugawara, K., & Sato, C. (1989). Ca2+−dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. The Journal of Biological Chemistry, 264(30), 18119–18127.
Ishigami, A., Ohsawa, T., Watanabe, K., & Senshu, T. (1996). All-trans retinoic acid increases peptidylarginine deiminases in a newborn rat keratinocyte cell line. Biochemical and Biophysical Research Communications, 223(2), 299–303.
Ishigami, A., Kuramoto, M., Yamada, M., Watanabe, K., & Senshu, T. (1998). Molecular cloning of two novel types of peptidylarginine deiminase cDNAs from retinoic acid-treated culture of a newborn rat keratinocyte cell line. FEBS Letters, 433(1–2), 113–118.
Ishigami, A., Asaga, H., Ohsawa, T., Akiyama, K., & Maruyama, N. (2001). Peptidylarginine deiminase type I, type II, type III and type IV are expressed in rat epidermis. Biomedical Research, 22(1), 63–65.
Ishigami, A., Ohsawa, T., Asaga, H., Akiyama, K., Kuramoto, M., & Maruyama, N. (2002). Human peptidylarginine deiminase type II: Molecular cloning, gene organization, and expression in human skin. Archives of Biochemistry and Biophysics, 407(1), 25–31.
Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H., Kobayashi, S., Saito, Y., Murayama, S., Asaga, H., Toda, T., Kimura, N., & Maruyama, N. (2005). Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. Journal of Neuroscience Research, 80(1), 120–128.
Ishigami, A., Masutomi, H., Handa, S., Nakamura, M., Nakaya, S., Uchida, Y., Saito, Y., Murayama, S., Jang, B., Jeon, Y. C., Choi, E. K., Kim, Y. S., Kasahara, Y., Maruyama, N., & Toda, T. (2015). Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer’s disease brains. Journal of Neuroscience Research, 93(11), 1664–1674.
Jang, B., Kim, E., Choi, J. K., Jin, J. K., Kim, J. I., Ishigami, A., Maruyama, N., Carp, R. I., Kim, Y. S., & Choi, E. K. (2008). Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: A possible role in pathogenesis. The American Journal of Pathology, 173(4), 1129–1142.
Jang, B., Jin, J. K., Jeon, Y. C., Cho, H. J., Ishigami, A., Choi, K. C., Carp, R. I., Maruyama, N., Kim, Y. S., & Choi, E. K. (2010). Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathologica, 119(2), 199–210.
Jang, B., Shin, H. Y., Choi, J. K., Nguyen du, P. T., Jeong, B. H., Ishigami, A., Maruyama, N., Carp, R. I., Kim, Y. S., & Choi, E. K. (2011). Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: Nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins. Journal of Neuropathology and Experimental Neurology, 70(2), 116–124.
Jang, B., Jeon, Y. C., Choi, J. K., Park, M., Kim, J. I., Ishigami, A., Maruyama, N., Carp, R. I., Kim, Y. S., & Choi, E. K. (2012). Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: Links between altered multifunction of enolase and neurodegenerative diseases. The Biochemical Journal, 445(2), 183–192.
Kanno, T., Kawada, A., Yamanouchi, J., Yosida-Noro, C., Yoshiki, A., Shiraiwa, M., Kusakabe, M., Manabe, M., Tezuka, T., & Takahara, H. (2000). Human peptidylarginine deiminase type III: Molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. The Journal of Investigative Dermatology, 115(5), 813–823.
Katzman, R. (1986). Alzheimer’s disease. The New England Journal of Medicine, 314(15), 964–973.
Keilhoff, G., Prell, T., Langnaese, K., Mawrin, C., Simon, M., Fansa, H., & Nicholas, A. P. (2008). Expression pattern of peptidylarginine deiminase in rat and human Schwann cells. Developmental Neurobiology, 68(1), 101–114.
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000). Impaired proteasome function in Alzheimer’s disease. Journal of Neurochemistry, 75(1), 436–439.
Kubilus, J., & Baden, H. P. (1983). Purification and properties of a brain enzyme which deiminates proteins. Biochimica et Biophysica Acta, 745(3), 285–291.
Kubilus, J., Waitkus, R. F., & Baden, H. P. (1980). Partial purification and specificity of an arginine-converting enzyme from bovine epidermis. Biochimica et Biophysica Acta, 615(1), 246–251.
Lamensa, J. W., & Moscarello, M. A. (1993). Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain. Journal of Neurochemistry, 61(3), 987–996.
Lange, S., Gogel, S., Leung, K. Y., Vernay, B., Nicholas, A. P., Causey, C. P., Thompson, P. R., Greene, N. D., & Ferretti, P. (2011). Protein deiminases: New players in the developmentally regulated loss of neural regenerative ability. Developmental Biology, 355(2), 205–214.
Liu, Y. L., Chiang, Y. H., Liu, G. Y., & Hung, H. C. (2011). Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4). PloS One, 6(6), e21314.
Maccioni, R. B., Munoz, J. P., & Barbeito, L. (2001). The molecular bases of Alzheimer’s disease and other neurodegenerative disorders. Archives of Medical Research, 32(5), 367–381.
Masutomi, H., Kawashima, S., Kondo, Y., Uchida, Y., Jang, B., Choi, E. K., Kim, Y. S., Shimokado, K., & Ishigami, A. (2016). Induction of paptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells. Journal of Neuroscience Research, 95(7), 1503–1512. doi:10.1002/jnr.23959.
Matsushita, K., Wakamori, M., Rhyu, I. J., Arii, T., Oda, S., Mori, Y., & Imoto, K. (2002). Bidirectional alterations in cerebellar synaptic transmission of tottering and rolling Ca2+ channel mutant mice. The Journal of Neuroscience, 22(11), 4388–4398.
Moscarello, M. A., Wood, D. D., Ackerley, C., & Boulias, C. (1994). Myelin in multiple sclerosis is developmentally immature. The Journal of Clinical Investigation, 94(1), 146–154.
Moscarello, M. A., Pritzker, L., Mastronardi, F. G., & Wood, D. D. (2002). Peptidylarginine deiminase: A candidate factor in demyelinating disease. Journal of Neurochemistry, 81(2), 335–343.
Moscarello, M. A., Mastronardi, F. G., & Wood, D. D. (2007). The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochemical Research, 32(2), 251–256.
Musse, A. A., Li, Z., Ackerley, C. A., Bienzle, D., Lei, H., Poma, R., Harauz, G., Moscarello, M. A., & Mastronardi, F. G. (2008). Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Disease Models & Mechanisms, 1(4–5), 229–240.
Nakashima, K., Hagiwara, T., Ishigami, A., Nagata, S., Asaga, H., Kuramoto, M., Senshu, T., & Yamada, M. (1999). Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). The Journal of Biological Chemistry, 274(39), 27786–27792.
Nishijyo, T., Kawada, A., Kanno, T., Shiraiwa, M., & Takahara, H. (1997). Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat. J. Biochem. (Tokyo), 121(5), 868–875.
Rogers, G. E., & Simmonds, D. H. (1958). Content of citrulline and other amino acids in a protein of hair follicles. Nature, 182, 186–187.
Rus'd, A. A., Ikejiri, Y., Ono, H., Yonekawa, T., Shiraiwa, M., Kawada, A., & Takahara, H. (1999). Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. European Journal of Biochemistry, 259(3), 660–669.
Senshu, T., Sato, T., Inoue, T., Akiyama, K., & Asaga, H. (1992). Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Analytical Biochemistry, 203(1), 94–100.
Senshu, T., Akiyama, K., Kan, S., Asaga, H., Ishigami, A., & Manabe, M. (1995). Detection of deiminated proteins in rat skin: Probing with a monospecific antibody after modification of citrulline residues. The Journal of Investigative Dermatology, 105(2), 163–169.
Senshu, T., Akiyama, K., Ishigami, A., & Nomura, K. (1999). Studies on specificity of peptidylarginine deiminase reactions using an immunochemical probe that recognizes an enzymatically deiminated partial sequence of mouse keratin K1. Journal of Dermatological Science, 21(2), 113–126.
Serdaroglu, M., Cakirbay, H., Deger, O., Cengiz, S., & Kul, S. (2008). The association of anti-CCP antibodies with disease activity in rheumatoid arthritis. Rheumatology International, 28(10), 965–970.
Servais, L., Bearzatto, B., Schwaller, B., Dumont, M., De Saedeleer, C., Dan, B., Barski, J. J., Schiffmann, S. N., & Cheron, G. (2005). Mono- and dual-frequency fast cerebellar oscillation in mice lacking parvalbumin and/or calbindin D-28k. The European Journal of Neuroscience, 22(4), 861–870.
Shimada, N., Handa, S., Uchida, Y., Fukuda, M., Maruyama, N., Asaga, H., Choi, E. K., Lee, J., & Ishigami, A. (2010). Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain. Journal of Neuroscience Research, 88(4), 798–806.
Smith, M. A. (1998). Alzheimer disease. International Review of Neurobiology, 42, 1–54.
Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., Ohtsuki, M., Furukawa, H., Yoshino, S., Yukioka, M., Tohma, S., Matsubara, T., Wakitani, S., Teshima, R., Nishioka, Y., Sekine, A., Iida, A., Takahashi, A., Tsunoda, T., Nakamura, Y., & Yamamoto, K. (2003). Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nature Genetics, 34(4), 395–402.
Takizawa, Y., Sawada, T., Suzuki, A., Yamada, R., Inoue, T., & Yamamoto, K. (2005). Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scandinavian Journal of Rheumatology, 34(3), 212–215.
Tarcsa, E., Marekov, L. N., Mei, G., Melino, G., Lee, S.-C., & Steinert, P. M. (1996). Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. The Journal of Biological Chemistry, 271(48), 30709–30716.
Terakawa, H., Takahara, H., & Sugawara, K. (1991). Three types of mouse peptidylarginine deiminase: Characterization and tissue distribution. Journal of Biochemistry (Tokyo), 110(4), 661–666.
Tian, J., Shi, J., Bailey, K., & Mann, D. M. (2004). Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer’s disease. Neuropathology and Applied Neurobiology, 30(1), 46–56.
Tsuchida, M., Takahara, H., Minami, N., Arai, T., Kobayashi, Y., Tsujimoto, H., Fukazawa, C., & Sugawara, K. (1993). cDNA nucleotide sequence and primary structure of mouse uterine peptidylarginine deiminase. Detection of a 3′-untranslated nucleotide sequence common to the mRNA of transiently expressed genes and rapid turnover of this enzyme’s mRNA in the estrous cycle. European Journal of Biochemistry, 215(3), 677–685.
Vincent, S. R., Leung, E., & Watanabe, K. (1992). Immunohistochemical localization of peptidylarginine deiminase in the rat brain. Journal of Chemical Neuroanatomy, 5(2), 159–168.
Wagner, E., Skoumal, M., Bayer, P. M., & Klaushofer, K. (2009). Antibody against mutated citrullinated vimentin: A new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatology International, 29(11), 1315–1321.
Wakoh, T., Uekawa, N., Terauchi, K., Sugimoto, M., Ishigami, A., Shimada, J., & Maruyama, M. (2009). Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression. Biochemical and Biophysical Research Communications, 380(4), 807–812.
Watanabe, K., & Senshu, T. (1989). Isolation and characterization of cDNA clones encoding rat skeletal muscle peptidylarginine deiminase. The Journal of Biological Chemistry, 264(26), 15255–15260.
Watanabe, K., Akiyama, K., Hikichi, K., Ohtsuka, R., Okuyama, A., & Senshu, T. (1988). Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochimica et Biophysica Acta, 966(3), 375–383.
Whitney, E. R., Kemper, T. L., Bauman, M. L., Rosene, D. L., & Blatt, G. J. (2008). Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: A stereological experiment using calbindin-D28k. Cerebellum, 7(3), 406–416.
Wood, D. D., Ackerley, C. A., Brand, B., Zhang, L., Raijmakers, R., Mastronardi, F. G., & Moscarello, M. A. (2008). Myelin localization of peptidylarginine deiminases 2 and 4: Comparison of PAD2 and PAD4 activities. Laboratory Investigation, 88(4), 354–364.
Zarabian, B., Koushesh, F., & Vassef, A. (1987). Modified methods for measuring citrulline and carbamoyl-beta-alanine with reduced light sensitivity and sucrose interference. Analytical Biochemistry, 166(1), 113–119.
Zhao, J., Zhao, Y., He, J., Jia, R., & Li, Z. (2008). Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. The Journal of Rheumatology, 35(6), 969–974.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kondo, Y., Choi, EK., Kim, YS., Ishigami, A. (2017). Update on Deimination in Alzheimer’s Disease. In: Nicholas, A., Bhattacharya, S., Thompson, P. (eds) Protein Deimination in Human Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-58244-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-58244-3_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58243-6
Online ISBN: 978-3-319-58244-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)